Publication | Closed Access

Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle™) and recombinant follitropin-β for in vitro fertilization: a prospective, randomized study

FertilityReproductive HealthGynecologyRecombinant Follitropin-βReproductive MedicineReproductive BiologyPublic HealthEndocrinologyMedicineReproductive BiotechnologyVitro FertilizationHuman ReproductionReproductive Endocrinology